11 million bottles of acetominophen recalled

20 November 2006

The US Food and Drug Administration has recalled 11 million bottles of a widely-used painkiller from 129 retailers, including the world's largest retailer, Wal-Mart. Allegan, Michigan-based drugmaker Perrigo reported that about 200 500mg acetominophen caplets out of 70 million that were tested in the firm's production facility were found to contain metal fragments. The discovery was made after the firm realized that its manufacturing equipment was wearing out faster than expected.

The FDA said that the risk of serious injury was remote to patients using the affected caplets, although minor stomach discomfort and cuts to the mouth and throat were listed as potential hazards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight